Low-density lipoprotein particle size distribution in end-stage renal disease treated with hemodialysis or peritoneal dialysis

American Journal of Kidney Diseases

Volumn 27, Issue 1, 1996, Pages 84-91

  O'Neal, D ^a   Lee, P ^a   Murphy, B ^a   Best, J ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

End stage renal disease; hemodialysis; low density lipoprotein; peritoneal dialysis

Indexed keywords

ALBUMIN; APOLIPOPROTEIN A; APOLIPOPROTEIN A1; APOLIPOPROTEIN B100; CHOLESTEROL; CREATININE; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; CONTROLLED STUDY; DYSLIPIDEMIA; FEMALE; HEMODIALYSIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; IMMUNORADIOMETRIC ASSAY; KIDNEY FAILURE; KIDNEY FUNCTION; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; NEPHELOMETRY; PARTICLE SIZE;

EID: 0030028048     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0272-6386(96)90034-7     Document Type: Article

References (47)

1. CM Kjellstrand B Hylander A Collins Mortality on dialysis On the influence of early start, patient characteristics, and transplantation and acceptance rates ed 2 Am J Kidney Dis 15 1990 483 490
2. AP Disney Fifteenth report of the Australia and New Zealand Dialysis and Transplant Registry 1992
3. R Gokal J King S Bogle F Marsh D Oliver C Jakubowski L Hunt R Baillod C Ogg M Ward R Wilkinson Outcome in patients on continuous ambulatory peritoneal dialysis and hemodialysis: 4 Year analysis of a prospective multicentre study Lancet 2 1987 1105 1109
4. United States Renal Data System Annual Data Report 1990 Am J Kidney Dis 16 1990 S44 S52 (suppl)
5. World Health Annual Statistics. Geneva, Switzerland, World Health Organization, 1990, pp 166–169
6. KW Ma EL Greene L Raij Cardiovascular risk factors in the chronic renal failure and hemodialysis population Am J Kidney Dis 19 1992 505 513
7. JD Bagdade D Porte Jr EL Bierman Hypertriglyceridemia: A metabolic consequence of chronic renal failure N Engl J Med 279 1968 181 185
8. JD Brunzell JJ Albers LB Haas AP Goldberg L Agadoa DJ Sherrard Prevalence of serum lipid abnormalities in chronic hemodialysis Metabolism 26 1977 903 910
9. P-O Attman P Alaupovic A Gustafson Serum apolipoprotein profile of patients with chronic renal failure Kidney Int 32 1987 368 375
10. MK Chan Z Varghese JW Persaud RA Baillod JF Moorhead Hyperlipidemia in patients on maintenance hemo- and peritoneal dialysis The relative pathogenetic roles of triglyceride production and triglyceride removal ed 2 Clin Nephrol 17 1982 183 190
11. DC Cattran SSA Fenton DR Wilson G Steiner Defective triglyceride removal in lipemia associated with peritoneal dialysis and hemodialysis Ann Intern Med 85 1976 29 33
12. J Rubies-Prat E Espinel J Joven MR Ras L Pira High density lipoprotein subfractions in chronic uremia Am J Kidney Dis 9 1987 60 65
13. M Senti R Romero J Pedro-Botet A Pelegri X Nogues J Rubies-Prat Lipoprotein abnormalities in hyperlipidemic and normolipidemic men on hemodialysis with chronic renal failure Kidney Int 41 1992 1394 1399
14. P-O Attman P Alaupovic Lipid and apolipoprotein profile of uremic dyslipoproteinemia-relation to renal function and dialysis Nephron 57 1991 401 410
15. F Bergesio G Monzani R Ciuti A Serruto A Benucci V Frizzi M Salvadori Lipids and apolipoproteins changes during the progression of chronic renal failure Clin Nephrol 38 1992 264 270
16. P Grutzmacher W Marz B Peschke W Gross W Schoeppe Lipoproteins and apolipoproteins during the progression of chronic renal failure Nephron 50 1988 103 111
17. MK Chan J Persaud Z Varghese JF Moorhead Pathogenetic roles of post-heparin lipases in lipid abnormalities in hemodialysis patients Kidney Int 25 1984 812 818
18. B Lindholm HE Norbeck Serum lipids and lipoproteins during continuous ambulatory peritoneal dialysis Acta Med Scand 220 1986 143 151
19. T Shoji Y Nishizawa H Nishitani M Yamakawa H Morii Role of hypoalbuminemia and lipoprotein lipase on hyperlipoproteinemia in continuous ambulatory peritoneal dialysis Metabolism 40 1991 1002 1008
20. PJ Nestel NH Fidge MH Tan Increased lipoprotein-remnant formation in chronic renal failure N Engl J Med 307 1982 329 333
21. MA Austin JL Breslow CH Hennekens JE Buring WC Willet RM Krauss Low density lipoprotein subclass pattern and the risk of myocardial infarction JAMA 260 1988 1917 1921
22. J Coresh PO Kwiterovitch HH Smith PS Bachorik Association of plasma triglyceride concentration and LDL particle diameter, density and chemical composition with premature coronary artery disease in men and women J Lipid Res 34 1993 1687 1697
23. MA Austin Triglyceride, small dense LDL, and coronary artery disease Atherosclerosis 109 1994 259 (abstr)
24. DE Goldstein HM Wiedmeyer JD England RR Little KM Parker Recent advances in glycosylated hemoglobin measurements Crit Rev Clin Lab Sci 21 1984 187 228
25. WT Friedewald RI Levy DS Fredrickson Estimation of the concentration of low density lipoprotein cholesterol in plasma, without the use of the preparative centrifuge Clin Chem 18 1972 499 502
26. JJ Albers SM Marcovina MS Lodge The unique lipoprotein(a): properties and immunochemical measurement Clin Chem 36 1990 2019 2026
27. BH Chung JP Segrest MJ Ray JD Brunzell JE Hokanson RM Krauss K Beaudrie JT Cone Single vertical spin density gradient ultracentrifugation JP Segrest JJ Albers Methods in Enzymology 1986 Academic Press San Diego, CA 181 209
28. RM Krauss DJ Burke Identification of multiple subclasses of plasma low density lipoproteins in normal humans J Lipid Res 23 1982 97 104
29. HE Norbeck LA Carlson The uremic dyslipoproteinemia: Its characteristics and relations to clinical factors Acta Med Scand 209 1981 489 503
30. AK Cheung LL Wu C Kablitz J Leypoldt Atherogenic lipids and lipoproteins in hemodialysis patients Am J Kidney Dis 22 1993 271 276
31. C Heuck E Ritz Hyperlipoproteinemia in renal insufficiency Nephron 25 1980 1 7
32. D Applebaum-Bowden AP Goldberg WR Hazzard DJ Sherrard JD Brunzell JK Huttunen EA Nikkila C Ehnholm Postheparin plasma triglyceride lipases in chronic hemodialysis: Evidence for a role for hepatic lipase in lipoprotein metabolism Metabolism 28 1979 917 924
33. H Dieplinger PY Schoenfeld CJ Fielding Plasma cholesterol metabolism in end stage renal disease—Difference between treatment by hemodialysis or peritoneal dialysis J Clin Invest 77 1986 1071 1083
34. A Sniderman K Cianflone PO Kwiterovich T Hutchinson P Barre S Pritchard Hyperapobetalipoproteinemia—The major dyslipoproteinemia in patients with chronic renal failure treated with chronic ambulatory peritoneal dialysis Atherosclerosis 65 1987 257 265
35. MM Avram P Goldwasser D Burrell A Antigneni P Fein N Mittman The uremic dyslipidemia: A cross sectional and longitudinal study Am J Kidney Dis 20 1992 324 335
36. J Steele T Billington ED Janus J Moran Lipids, lipoproteins and apolipoproteins A1 and B and apoprotein losses in continuous ambulatory peritoneal dialysis Atherosclerosis 79 1989 47 50
37. GM Reaven Y-DI Chen J Jeppesen P Maheux RM Krauss Insulin resistance and hyperinsulinemia in individuals with small, dense, low density lipoprotein particles J Clin Invest 92 1993 141 146
38. GM Reaven Role of insulin resistance in human disease Diabetes 37 1988 1595 1607
39. E Ferrannini SM Haffner BD Mitchell MP Stern Hyperinsulinemia: The key feature of a cardiovascular and metabolic syndrome Diabetologia 3 1991 416 422
40. RA DeFronzo A Alvestrand D Smith R Hendler E Hendler J Wahren Insulin resistance in uremia J Clin Invest 67 1981 563 568
41. D Smith RA DeFronzo Insulin resistance in uremia mediated by postbinding defects Kidney Int 22 1982 54 62
42. RA DeFronzo D Smith A Alvestrand Insulin action in uremia Kidney Int 16 1983 S102 S114
43. M Oimomi K Ishikawa T Kawasaki S Kubota Y Yoshimura S Baba Carbamylation of hemoglobin in renal failure and clinical aspects Metabolism 33 1984 999 1002
44. GP Grodstein MJ Blumenkrantz JD Kopple JK Moran JW Coburn Glucose absorption during continuous ambulatory peritoneal dialysis Kidney Int 19 1981 564 567
45. AG Marangou KM Weber RC Boston PM Aitken JCP Heggie LG Kirsner JD Best FP Alford Metabolic consequences of prolonged hyperinsulinemia in humans Diabetes 35 1986 1383 1389
46. MJ Blumenkrantz AM Gahl JD Kopple AV Kamdar MR Jones M Kessel CW Coburn Protein losses during peritoneal dialysis Kidney Int 19 1981 593 602
47. J Marsh D Drabkin Experimental reconstitution of metabolic pattern of lipid nephrosis: Key role of hepatic protein synthesis in hyperlipidemia Metabolism 9 1960 946 955